⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

EW · Edwards Lifesciences Corporation

$87.84 latest stored close
Detected setup Wyckoff SOS

Watch · Quality 21/100

Ask about EW

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / EW

$EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $51B.

Neutral · 53 Health Technology Medical Specialties stock Stage 2 · Advancing Base 2 Data 1h 57m ago
$87.84 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Normal technical setup

Thursday, July 23, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

EW+0.65%
Sector proxy · XLV+2.22%
Broad market · SPY-0.54%
Same completed session window ending 2026-07-16. EW was -1.57 points vs XLV. +1.19 points vs SPY. Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $87.84 Jul 16 close
52W High $96.29 -8.8%
52W Low $72.30
Wks Since High 1w
Base Depth -10.3%
Base B2
SMA 50 $86.85
SMA 200 $83.20
Avg Vol 4,923,665
RS Rank 33
RS vs High -9.9%
RS Slope +0.0% ▲
Grp Rank #48/64
ADR% 2.6%
ATR(14) $2.51 (2.9%)
Rel Vol (today) 1.21×
Vol Pace N/A
U/D Vol 0.89
A/D Days 19A / 15D
A/D Rating A
VDU Bars 0/10 d
Earnings past
$72.30
$96.29 65%

EW Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for EW.

Create Free Account
Setup Quality B 4/7 signals
Jul 15: 60 (Wyckoff SOS)Jul 15: 60 (Wyckoff SOS)Jul 16: 71 (Wyckoff SOS)Jul 16: 71 (Wyckoff SOS)Jul 16: 72 (Wyckoff SOS)Jul 17: 68 (Wyckoff SOS)68 Score trend
✓ Stage 2 · Advancing ✗ Power Trend ✗ RS New High ✓ Trend 6/8 ✗ No Pattern ✓ CANSLIM 71.2 (B) ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$EW · $87.84 · as of 2026-07-16 · multi-factor read
53
/ 100
Neutral

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$86.85 ↑
100-day$84.52 ↑
200-day$83.20 ↑
Bullish (50 > 200)

RSI (14)

Reading45.0 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateWeakening
Histogram-0.732

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width27% · 12.5%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol0.89 · Neutral
Rel volume1.21×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $89.48swing level
R · $96.2952-week high
Price · $87.84now
S · $83.17swing level
S · $80.88swing level
S · $77.20swing level

Fibonacci · Uptrend swing

23.6%$91.19
38.2% ◄ price here$88.03
50.0%$85.47
61.8%$82.92
78.6%$79.29

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for EW — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Weekly uptrendAbove 200-day MA50/200 bullishRS 30 (laggard)
Want this read in a legend's voice? 💬 Ask a Legend about EW
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 9/13 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $87.84, MA150 $83.97, MA200 $83.20
1.2 150-day MA > 200-day MAMA150 $83.97 vs MA200 $83.20
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 30
2. ROE ≥ 17%ROE 10.6%
9/13 checks
Avoid
O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence
C: Quarterly EPS acceleration ≥ 25%+34.5% QoQ
N: Near 52-week high or RS line new high8.8% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 30
A: Annual earnings & revenue qualityRev +11.6% | ROE 10.6%
3/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $87.84 vs MA200 $83.20
Failing evidence
Volume expansion above averageVolume ratio 1.21x
Relative strength ≥ 60RS 30
4/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$87.84
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 30
Volume vs average1.21x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$87.84
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 30
Volume vs average1.21x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$87.84
Distance from 52-week high8.8% below high
Failing evidence
Relative strengthRS 30
Volume vs average1.21x
3/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

🕯 Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
95RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +5 A
A: 17 D: 12 Net: +565 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B 4/7 SEPA
Separate score from the 8-point Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ +34%
Revenue growth ≥20% YoY +12%
Gross margin ≥30% 78%
ROE ≥17% 11%
RS rating ≥80 (leadership) 30
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -8.8%

Method Playbook

📋 Trade it like Minervini EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Minervini C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
No active setup in the latest scan — showing last result from 11 days ago. Patterns may no longer be valid. Run a new scan →

Pattern Analysis (historical · 11d ago)

67.9 score
RS Score 30
Trend 6/8
CANSLIM 71.2* (B)
range low: 77.399 range high: 84.972 range pct: 0.098 sos thrust: 0.068 sos vol ratio: 2.904 sos bars ago: 13 near lps: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup? D+W Confluence
Wyckoff SOS

SOS: breakout above range_high=84.97, thrust=6.8%, vol=2.9x avg, lps=near, 13 bars ago | Moderate trend (6/8) | High-confidence pattern (95%) | Stage 2 | Readiness 67/100 (watch) | CANSLIM 71.2 (B)

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $87.84 vs SMA150 $83.97 / SMA200 $83.20
SMA 150 above SMA 200 SMA150 $83.97 vs SMA200 $83.20
SMA 200 trending up Slope +1.30 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $86.85
Price above SMA 50 $87.84 vs SMA50 $86.85
30%+ above 52W low +21.5% from $72.30
Within 25% of 52W high -8.8% from $96.29
RS score above 70 RS 30

Fundamentals

52W Range
65%
Mkt Cap SEC
50.6B
EPS QoQ
+34%
Rev YoY
+12%
ROE
11%
Gross Margin
78%
D/E
0.06
EPS TTM
$1.83
P/E TTM
48.0x
Float
576M
Insider
No Buy

Company

Legend AI snapshot
Edwards Lifesciences Corporation
EW · NYSE · Health Technology · Medical Specialties
$87.84latest close $50.6Bmarket cap 33RS rank 68setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 71.2* CANSLIM * disqualified on M
C · Curr. EPS
100
A · Annual EPS
69
N · New Highs
100
S · Supply/Demand
100
L · Leader RS
30
I · Inst. Spons.
96
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
6/8
W. RS
69
W. Support
$74.66
W. Resist
$96.29
W. Patterns
Basing
Weekly Structure

Scan History

Jul 15: 60 (Wyckoff SOS)Jul 15: 60 (Wyckoff SOS)Jul 16: 71 (Wyckoff SOS)Jul 16: 71 (Wyckoff SOS)Jul 16: 72 (Wyckoff SOS)Jul 17: 68 (Wyckoff SOS)68
Jul 17
Wyckoff SOS ✓ Gate
68
Jul 16
Wyckoff SOS ✓ Gate
72 0.0%
Jul 16
Wyckoff SOS ✓ Gate
71 0.0%
Jul 16
Wyckoff SOS ✓ Gate
71 0.0%
Jul 15
Wyckoff SOS ✓ Gate
60 +0.7%
Jul 15
Wyckoff SOS ✓ Gate
60 +0.7%

Get the full picture on EW

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial